Author Archive

Daniel Coriat Sharing the Results of the BCI 2017 | Hosted by the CIF

Posted by:

In Santiago de Chile, Daniel Coriat shared the results of the BCI 2017 with a distinguished audience at an event hosted by CIF, the local Chilean pharmaceutical trade association.  During the event, representatives of the Ministry of Economy and the Ministry of Foreign Affairs highlighted the importance that the BCI tool provides as empirical evidence of the effects of public policy.  Here Dan is being interviewed by a renowned journalist in Chile about the BCI:

http://www.infinita.cl/entrevistas/2018/05/09/daniel-coriat-director-consultora-pugatch-consilium

Continue Reading →
0

Is Taiwan Ready for the Top Spot?

Posted by:

Professor Meir Pugatch spoke today at the forum “Positioning Taiwan as an Asia-Pacific Biomedical R&D Hub” which took place the International Convention Center in Taipei, and included the Vice President of Taiwan and additional government officials.

Professor Pugatch presented a comprehensive analysis of Taiwan’s competitiveness in the biotech sector, as well as recent improvements to and remaining challenges in Taiwan’s path to leadership in global biotech innovation.

By utilizing a competitive mentality that views policy as instrumental in achieving economic and societal ...

Continue Reading →
0

Daniel Coriat on Colombia’s standing in the BCI report

Posted by:

As part of the coverage of the event celebrating 60 years of Afidro where industry, government, patient groups and other stakeholders gathered in Bogota on March 2018, a leading 24-hour news channels in Colombia interviews Pugatch Consilium’s Daniel Coriat on Colombia’s standing in the BCI report. Daniel explains how policies not geared to promote innovation hurt Colombia’s international standing and competitiveness in attracting foreign direct investment.

Listen to the interview

Continue Reading →
0

III Semana de Innovación en Salud (Week of Innovation in Health) Event

Posted by:

Ma’ayan Laufer, a Senior Consultant at Pugatch Consilium, spoke last week at the III Semana de Innovación en Salud (Week of Innovation in Health) event, held at Mexico City. Ma’ayan’s presentation focused on Mexico’s performance vis-à-vis global leaders in biomedical innovation as reflected in Pugatch Consilium’s international indices – including the Building the Bioeconomy series, the International IP Index and the Biopharmaceutical Competitiveness and Investment (BCI) Index.

Continue Reading →

0

Pugatch Consilium’s BCI Survey used at the BioBusiness Asia Conference

Posted by:

Pugatch Consilium’s Biopharmaceutical Competitiveness & Investment Survey – known as the BCI – gained much attention when presented by Taiwan’s Vice-President, Chien-Jen Chen in his opening remarks at the BioBusiness Asia Conference which took place last week in Taipei.

VP Chen discussed the growth and development of Taiwan’s biotech industry, the challenges that still remain, and the new governmental policies in six areas of priorities in the biomedical industry, including increased efforts to harmonize the IP and legislative environments with international ...

Continue Reading →
0

Separating Fact from Fiction – How Localization Barriers Fail Where Positive Non-discriminatory Incentives Succeed

Posted by:

More in number and more draconian – Localization barriers have grown in number and intensity over the last decade. Our new study – Separating Fact from Fiction: How Localization Barriers Fail Where Positive Non-discriminatory Incentives Succeed – finds that over the last 5-10 years industrial aspirations and concern over their dependence on global supply chains have led many emerging markets to seek to bolster or create indigenous sectors through introducing protectionist-like measures.

However, the study also finds that restrictive and punitive ...

Continue Reading →
0

Pugatch Consilium at the Mexican Senate and IMPI event on promoting economic development and industrial competitiveness in Mexico

Posted by:

Dr. David Torstensson spoke yesterday at the Mexican Senate and IMPI (the Mexican industrial property institute) event entitled: “First day for an original Mexico – promoting the culture of industrial property” (Primera Jornada por un México Original: Promoviendo la cultura de la propiedad industrial). With the aim of increasing awareness to the importance of IP protection to economic development, numerous representatives of public and private institutions analyzed the current state of the Mexican IP environment, with a particular focus on ...

Continue Reading →
0

Infinite Possibilities

Posted by:

Professor Meir Pugatch spoke at the launch of the fourth edition of the U.S. Chamber’s International IP Index. Titled: Infinite Possibilities, this edition maps and benchmarks the intellectual property environment in 38 economies, which together account for nearly 85% of global gross domestic product (GDP). On the whole, while challenges and setbacks still exist across the board, many of the benchmarked countries have taken positive steps and improved their IP environments. The Index also includes a special annex which underscores ...

Continue Reading →
0

The Next Frontier in Ensuring the Quality of Medicines: Maintaining International Quality and Safety Standards in the Manufacturing and Supply of Active Pharmaceutical Ingredients

Posted by:

Today Pugatch Consilium launches The Next Frontier in Ensuring the Quality of Medicines: Maintaining International Quality and Safety Standards in the Manufacturing and Supply of Active Pharmaceutical Ingredients. Authored by Professor Meir Pugatch, Dr. David Torstensson and Ma’ayan Laufer this report provides a deep-dive analysis of the next generation of challenges facing drug regulators across the globe.

Pharmacovigilance is the name given to the mechanisms and tests that together map and ensure the safety of a medicine throughout its life span ...

Continue Reading →
0
Page 1 of 3 123